Eric Lefkofsky Tempus Unicorn Funding

Tempus Unicorn is a technology company based in Chicago that has built an operating system to fight against the chronic disease like cancer. Eric Lefkofsky is the CEO and the co-founder of Tempus and also the chairman of Groupon Company. The organization uses optical character recognition, manual curation, and natural language processing to personalize cancer care and to improve its efficiency.

Tempus has raised $80 million in March 2018 courtesy of new and existing investors as headcount doubled in the past eighteen months. Tempus is valued to be about $1.1 billion as per the price and funds advised by the Chicago-based investment fund, Kinship Trust.

The company has raised about $210 million since the start of its operation. Other Business partners took an interest in such a noble course initiated by Alex Lefkofsky, have therefore invested along with the firm fighting to eradicate cancer.

With the need of providing adequate and professional techniques to deal with cancer treatment, Lefkofsky built up a team of data-science and technology experts and other people who are familiar with cancer research. The company increased the number of academic medical centers by 50% and employed more specialized cancer doctors to achieve the objective set by the team of medical experts.

The company is striving hard in delivering better services across the states. Since the company uses advanced technology, the primary mission is to collect and analyze data to assist doctors on information about options of treating cancer patients. Consequently, impart knowledge to understand how patients with similar genetic characteristics have responded to particular treatments.

Tempus has built a clinical and molecular data library for easy access to medical reference using an efficient system that guides in prescribing cancer medicine and other types of chronic diseases. As the organization continues to grow through expansion of facilities, employees are also hired to scale the size of the team and the database. Medical laboratories are also expanded to accommodate the increasing number.

Lefkofsky embraces technology as it is the foundation transforming the company. Their social and economic imperative to make useful, accessible and a better healthcare system was a breakthrough means of treating chronic diseases.